Company:  DERMIRA, INC.
Form Type:  SC 13G/A
Filing Date:  2/16/2021 
CIK:  0001557883 
Address:  275 MIDDLEFIELD ROAD
SUITE 150
 
City, State, Zip:  MENLO PARK, California 94025 
Telephone:  650 421 7200 
Fiscal Year:  12/31 
Description of Business
We are a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions. We are committed to understanding the needs of both patients and physicians and using our insight to identify, develop and commercialize leading-edge medical dermatology products. Our approved treatment, QBREXZA(TM) (glycopyrronium) cloth ("QBREXZA"), is indicated for pediatric and adult patients (ages nine and older) with primary axillary hyperhidrosis (excessive underarm sweating). We are also evaluating lebrikizumab in a Phase 2b clinical trial for the treatment of moderate-to-severe atopic dermatitis (a severe form of eczema) and have early-stage research and development programs in other areas of dermatology. We are headquartered in Menlo Park, California.
Register and access this filing in:     
  FORM SC 13G/A
  EXHIBIT 99.1